Current (not recruiting)

To codesign the PrEP STAT package using a designathon (Phase 1) 

To test the prototype PrEP STAT package with overseas-born GBM on the acceptability of the package (Phase 2)

To test the feasibility of implementing PrEP STAT through a pilot study (Phase 3) 

Pay PrEP forward

PrEP-it-forward

Support other Medicare-ineligible peers to have the opportunity to access PrEP
 

PrEP it forward

About the study

We want to address the inequality in the HIV response by evaluating whether the provision of the PrEP-STAT pack at the point of consultation at Melbourne Sexual Health Centre can improve the awareness, uptake and ongoing access/linkage to prevention among high-risk overseas-born GBM. Same-day PrEP initiation has been successfully implemented in several settings and countries, with high acceptability and feasibility reported. Beyond the same-day provision of one-month supply of Truvada, we will use a codesigned package from the focus community, including resources and motivational messaging informed by behavioural economics (Nudge theories).

Who do we want to talk to

  1. Self-identify as gay, bisexual men, queer or other men who have sex with men
  2. No access to Medicare
  3. At least 18 years old at the time of recruitment
  4. No prior HIV diagnosis or a positive HIV test result (Unknown is acceptable)

What's involved

In this trial, you will undergo a PrEP initiation process, meaning you will receive consultation about PrEP initiation and undertake an HIV test. The decision to initiate PrEP is voluntary. We will follow your PrEP journey. Through two surveys, we will ask you whether you have initiated and continued using PrEP and engaged in the donation system after today’s consultation. The surveys will be sent to your mobile number and email address that you provided to the MSHC within 30 and 90 days from today.
 
If you have health conditions, such as kidney problem, or take other medications, please consult with the clinician before participating in this research.

Researchers

Principal investigator

Professor Doctor Jason Ong PhD, MMed (First Class Honours), MBBS, FAChSHM, MAICD

Student investigator

Warittha Tieosapjaroen